Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis

Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/28736

Title:	Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis
Authors:	Marcellin, Patric Buti, Maria Krastev, Zahary Di Bisceglie, Adrian M. Odin, Joseph A. Dusheiko, Geoffrey Heathcote, E. Jenny E. Jenny, Katyna Coombs, Derek Mondou, Elsa Anderson, Jane Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. Gürel, Selim
Keywords:	Gastroenterology & hepatology
Issue Date:	Oct-2010
Publisher:	Wiley
Citation:	Marcellin, P. vd. (2010). "Continued efficacy and safety through 4 years of tenofovir disoproxil fumarate (tdf) treatment in hbeag-negative patients with chronic hepatitis b (study 102): Preliminary analysis". Hepatology, 52(4), Supplement, 555A-556A.
Description:	Bu çalışma, 29 Ekim-02 Kasım 2010 tarihleri arasında Boston[Amerika Birleşik Devletleri]’da düzenlenen 61. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.
URI:	http://hdl.handle.net/11452/28736
ISSN:	0270-9139
Appears in Collections:	Web of Science

Files in This Item:

There are no files associated with this item.

DSpace JSPUI